Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De Novo MET Amplification

Sai‐Hong Ignatius Ou, A. John Iafrate, Christina T. Siwak-Tapp et al.|Journal of Thoracic Oncology|2011

Cited by 439